Cancer drug developer Erasca picks up $42 mln Series A
San Diego-based Erasca, a creator of oncology drugs, has raised $42 million in Series A financing. City Hill Ventures and Cormorant Asset Management led the round.
18 December 2018•1 min read
San Diego-based Erasca, a creator of oncology drugs, has raised $42 million in Series A financing. City Hill Ventures and Cormorant Asset Management led the round.
